Testing version — LOERadar is in active testing. Features and data may change.

IOMERVU (IOMEPROL) | LOERadar

Viewing data from:

IOMERVU

NDA

IOMEPROL | N216017 | BRACCO DIAGNOSTICS INC

13 strengths0 unique patents1 unique exclusivity

Patent Timeline

0 unique patents, 1 exclusivity by expiration date

TodayExclusivity

2027

2028

2029

2030

Today

NCE

Nov. 27, 2029

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain1 active DMF1 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SUZHOU RYWAY BIOTECH CO LTDIOMEPROL

DMF 424282025

BRACCO IND CHIMICA SPAInactiveIOMEPROL

DMF 102991993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Nov 29, 2024	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (13)

Sort:

#001 — 25GM IODINE/100ML (250MG IODINE/ML)

RLD

0 patents1 exclusivity▴

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

Exclusivities (1)

Code	Date	Status
NCE	Nov 27, 2029	Active

#002 — 15GM IODINE/50ML (300MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#003 — 30GM IODINE/100ML (300MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#004 — 45GM IODINE/150ML (300MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#005 — 60GM IODINE/200ML (300MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#006 — 17.5GM IODINE/50ML (350MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#007 — 35GM IODINE/100ML (350MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#008 — 52.5GM IODINE/150ML (350MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#009 — 70GM IODINE/200ML (350MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#010 — 20GM IODINE/50ML (400MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#011 — 40GM IODINE/100ML (400MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#012 — 60GM IODINE/150ML (400MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024

#013 — 80GM IODINE/200ML (400MG IODINE/ML)

RLD

0 patents1 exclusivity▾

SOLUTION;INTRAVENOUS | Approved: Nov 27, 2024